Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of bilastine vs levocetirizine vs placebo in chronic idiopathic urticaria
2006-001245-33Phase 3Completed
- Sponsor
- Faes Farma
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bilastine in chronic idiopathic urticaria (CIU) (3 arms), sponsored by Faes Farma. Primary endpoint: Change from baseline in Total Symptom Score over 28 days (reflective symptoms). Started Jun 2006; status: completed.
02
Drugs
bilastine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on 2006-001245-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001245-33.